THBD and COVID-19: Our data add to the findings on various markers of endothelial cell and platelet activation, including vWf, soluble thrombomodulin, soluble CD40 ligand, and plasminogen activator inhibitor (PAI)-1, studied in COVID-19 [5,25,38].